Skin Care Research, LLC

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Alopecia areata2 trials
• Vitiligo2 trials

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Terminated2 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Incyte Corporation3 trials
• Evommune, Inc.1 trial
• Organon and Co1 trial
• Pfizer1 trial
• Sun Pharmaceutical Industries, Inc.1 trial

Running trials

• Active, not recruiting

  A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

  NCT07265479· Phase 3· Organon and Co· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

  NCT06548360· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

  NCT06113471· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

  NCT03898479· Phase 2/3· Sun Pharmaceutical Industries, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Vitiligo1 recruiting

Closed trials

• Completed

  Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

  NCT07150845· Phase 2· Evommune, Inc.· Source

• Terminated

  The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

  NCT05696392· Phase 4· Incyte Corporation· Source

• Terminated

  PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

  NCT04517864· Phase 2· Pfizer· Source